JONATHAN SOLOMON
Profile
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
KENNETH BUCKFIRE, VALERIE CALENDA, VALERIE CALENDA, PH.D., JOHN DEE, NICO DOSENBACH, RICHARD FISCHER, PH.D., RICHARD A. FISHER, PH.D., PAUL GOLDENHEIM, PAUL GOLDENHEIM, MD, FRANZ HEFTI, PH.D., HAMPUS HILLERSTROM, NICK LESCHLY, DANIEL LYNCH, DAVID MICHELSON, M.D., VICKI SATO, HANS SCHOEPFLIN, MARK SKALETSKY, PETER SMEDVIG, FRANCOIS VALENCONY
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2026-01-13
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2024-03-15
D
PHARMACEUTICALS
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2023-02-27

